• Featured Product
  • KD/KO Validated

DEK Rekombinanter Antikörper

DEK Rekombinant Antikörper für WB, IHC, IF/ICC, FC (Intra), Indirect ELISA

Wirt / Isotyp

Kaninchen / IgG

Getestete Reaktivität

human, Ratte

Anwendung

WB, IHC, IF/ICC, FC (Intra), Indirect ELISA

Konjugation

Unkonjugiert

CloneNo.

230065H2

Kat-Nr. : 82880-1-PBS

Synonyme

D6S231E, 230065H2



Geprüfte Anwendungen

Produktinformation

82880-1-PBS bindet in WB, IHC, IF/ICC, FC (Intra), Indirect ELISA DEK und zeigt Reaktivität mit human, Ratten

Getestete Reaktivität human, Ratte
Wirt / Isotyp Kaninchen / IgG
Klonalität Rekombinant
Typ Antikörper
Immunogen DEK fusion protein Ag8225
Vollständiger Name DEK oncogene
Berechnetes Molekulargewicht 43 kDa
Beobachtetes Molekulargewicht 45-50 kDa
GenBank-ZugangsnummerBC035259
Gene symbol DEK
Gene ID (NCBI) 7913
Konjugation Unkonjugiert
Form Liquid
Reinigungsmethode Protein-A-Reinigung
Lagerungspuffer PBS only
LagerungsbedingungenStore at -80°C. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

Dek oncogene(DEK) is first recognized in a fusion with CAN nucleoporin protein, and it's a also autoantigen in patients with pquciarticular onset juvenile rheumatoid arthritis. As a site-specific binding protein, DEK may involve in transcriptional regulation and signal transdcution. Analysis by agarose gel celctrophoresis, DEK showed to reduce the efficiency with which chromation is replicated. It's one of the first components of the splicing complex, which remains associate with spliced exons dependent on prior splicing of pre-mRNA.